688580.SS · 伟思医疗
China A-shares · RS rating 15 · As of 2026-10-14
| Price | 39.60 CNY |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 29 / 12 / 41 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 19 / 17 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +13.5% |
| Distance from 52-week high | +43.2% |
| Market cap (USD) | $596.1M |